Winship | Strategic Alliance Partners

January 21, 2021

Nabil F. Saba, MD, FACP, discusses the results of the JAVELIN Head and Neck 100 trial, as well as data from other key, recent studies in head and neck cancer.

January 14, 2021

Suresh S. Ramalingam, MD, FASCO, discusses the potential of HER2 as a driver mutation in non–small cell lung cancer.

December 22, 2020

Adam Marcus, PhD, has been appointed interim executive director of Winship Cancer Institute of Emory University, the National Cancer Institute–designated comprehensive cancer center for Georgia.

November 23, 2020

Sagar Lonial MD, FACP, discusses unanswered questions with T-cell engagers in myeloma.

November 17, 2020

Suresh S. Ramalingam, MD, FASCO, discusses limitations with immunotherapy in non–small cell lung cancer.

November 12, 2020

In our exclusive interview, Nabil F. Saba, MD, FACP, sheds light on the implications of targeting HRAS in head and neck squamous cell carcinoma, details the data that has been reported to date with tipifarnib, and shares his expectations for the ongoing KO-TIP-007 trial.